Peripheral InterventionalProcedures Flashcards
What procedure has shown noninferiority to traditional surgical carotid endarterectomy in high-risk populations?
Carotid artery stenting
Supported by several registries and the SAPPHIRE trial.
What was the primary endpoint of the SAPPHIRE trial?
Composite of death, stroke, and MI within 30 days
Results showed a 39% reduction in this endpoint for stenting.
What were the results regarding 1-year event-free survival in the SAPPHIRE trial?
88% for stenting vs. 79% for endarterectomy
Statistically significant with p = 0.048.
What are some criteria for high-risk candidates for carotid artery stenting?
- Age >80 years
- CHF III to IV
- EF < 30%
- Recent MI
- Unstable angina
- Severe pulmonary disease
- Contralateral laryngeal nerve palsy
These criteria were established based on clinical and anatomic considerations.
What did a recent meta-analysis conclude about stenting for symptomatic carotid stenosis in older patients?
Should be avoided in patients age ≥70 years
Stenting might be safe for younger patients.
What is the incidence of stroke post carotid artery stenting in high-risk patients?
Approaches 3%
Primary mechanism is distal embolization of atheromatous debris.
What complication can occur due to distention of the carotid sinus mechanoreceptors during stenting?
Hypotension and bradycardia
Occurs in up to 40% of procedures involving internal carotid lesions.
What was the incidence of MI within 30 days of carotid stenting in the SAPPHIRE trial?
1.9%
Significantly lower than after carotid endarterectomy.
What is the compensatory response of cerebral vessels to carotid occlusive disease?
Compensatory vasodilation
Aims to maintain adequate blood flow to the brain.
What are symptoms of hyperperfusion following carotid artery intervention?
- Throbbing headache
- Nausea
- Vomiting
- Visual changes
- Focal motor deficits
- Seizures
Symptoms can occur due to sudden increase in blood flow to dilated vasculature.
What is the initial test of choice for diagnosing PAD according to AHA Guidelines?
Resting ABI
ABI is calculated by dividing the highest dorsalis pedis or posterior tibial pressure by the highest arm pressure.
What is considered an abnormal ABI value indicating PAD?
ABI <0.9
Diagnosis is confirmed in symptomatic patients with this ABI.
What medications are FDA-approved for relief of claudication due to PAD?
- Pentoxifylline
- Cilostazol
Cilostazol is a type III phosphodiesterase inhibitor.
What was the result of cilostazol in a meta-analysis for patients with moderate to severe claudication?
Increased maximal walking distances by 50% and pain-free walking distances by 67%
Based on eight randomized trials.
What is the normal range for ABI?
1.00 to 1.40
Values above 1.40 suggest a noncompressible artery.
What is the recommendation for patients with claudication symptoms and abnormal ABI?
Undergo diagnostic testing for PAD
Patients with risk factors should also be tested.
What are the independent predictors of increased walking distances in exercise rehabilitation for PAD?
- Use of claudication endpoint
- Program length
- Mode of exercise
These factors were identified in a meta-analysis of 33 trials.
What is the significance of the Heart Protection Study regarding PAD?
Reduction in all-cause mortality by 13% and major vascular events by 24%
Study involved 20,536 patients with CAD, diabetes, or PAD.
What is the complication rate of PTA in the infrapopliteal vascular bed?
Not prohibitively high
Clear indications for PTA exist despite potential risks.
What are the lifestyle modifications recommended for patients with PAD?
- Aggressive management of diabetes
- Cessation of tobacco use
These modifications are essential alongside medical therapy.
What is the risk of limb loss for smokers with claudication symptoms?
20% risk of limb loss
Smokers have increased rates of disease progression.
What were the major adverse events reported in the studies?
No major adverse events such as death, MI, or limb loss were reported
MI stands for myocardial infarction.
What was the p-value indicating the increase in ABIs after intervention?
p = 0.0001
What is the recommended therapy for patients with PAD who smoke?
Pharmacologic therapy with varenicline, bupropion, and/or nicotine replacement
Referral to a smoking cessation program is also recommended.